US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Claritev Corporation

23.72

+2.4111.31%

Post-market: 23.720.00000.00%19:30 EDT

Volume:228.90K

Turnover:5.20M

Market Cap:402.45M

PE:-1.40

High:23.92

Open:21.97

Low:21.32

Close:21.31

52wk High:73.68

52wk Low:11.50

Shares:16.97M

Float Shares:5.67M

Volume Ratio:1.20

T/O Rate:4.04%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-16.9879

EPS(LYR):-17.3000

ROE:-646.34%

ROA:1.19%

PB:-1.37

PE(LYR):-1.37

Loading ...

Overview Company News Filings

Claritev Corp - Not Informed by DOJ That It Is Target of Investigation - SEC Filing

THOMSON REUTERS

Claritev says DOJ antitrust probe has not named company as target

Claritev price target raised to $40 from $21 at Citi

Humacyte Announces First Quarter 2026 Financial Results and Provides Business Update

Discovery Health partners smartQare, Cuviva to bolster Care at Home technology

Claritev to present at BofA Securities Global Health Care Conference

Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Thermo Fisher (TMO) and Claritev (CTEV)

Claritev (CTEV) Gets a Buy from Barclays

Claritev Corp reports results for the quarter ended March 31 - Earnings Summary

Claritev Q1 revenue beats estimates, lifts 2026 outlook

Claritev Q1 EPS $(4.41) Misses $(3.85) Estimate, Sales $244.678M Beat $236.389M Estimate

Benzinga Earnings

BRIEF-Claritev Corp Q1 Revenue USD 244.678 Million

Claritev Corp Q1 Net Income USD -73.56 Million

THOMSON REUTERS

Claritev Corp Q1 Pretax Profit USD -92.721 Million

THOMSON REUTERS

Press Release: Claritev Corporation Reports First Quarter 2026 Results

Claritev Corp expected to post a loss of $4.01 a share - Earnings Preview

Claritev shareholders approve 2,375,000-share increase to omnibus incentive plan

Claritev Initiated at Overweight by Barclays

Claritev schedules first-quarter earnings conference call

Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/CTEV/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CTEV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTEV\",,,,,undefined,":{"symbol":"CTEV","market":"US","secType":"STK","nameCN":"Claritev Corporation","latestPrice":23.72,"timestamp":1790971200000,"preClose":21.31,"halted":0,"volume":228899,"hourTrading":{"tag":"盘后","latestPrice":23.72,"preClose":23.72,"latestTime":"19:30 EDT","volume":11674,"amount":276940.46,"timestamp":1790983807762,"change":0,"changeRate":0,"amplitude":0.019393},"delay":0,"changeRate":0.11309244486156736,"floatShares":5671700,"shares":16966900,"eps":-16.987898,"marketStatus":"Closed","change":2.41,"latestTime":"10-02 16:00:00 EDT","open":21.97,"high":23.92,"low":21.32,"amount":5200543.162584,"amplitude":0.122008,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-16.987898,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":5,"adr":0,"exchange":"NYSE","adjPreClose":21.31,"preHourTrading":{"tag":"盘前","latestPrice":21.28,"preClose":21.31,"latestTime":"07:58 EDT","volume":10,"amount":212.8,"timestamp":1790942302513,"change":-0.03,"changeRate":-0.001408,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":23.72,"preClose":23.72,"latestTime":"19:30 EDT","volume":11674,"amount":276940.46,"timestamp":1790983807762,"change":0,"changeRate":0,"amplitude":0.019393},"volumeRatio":1.198064,"impliedVol":1.2146,"impliedVolPercentile":0.7131},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTEV\",,,,,undefined,":{"symbol":"CTEV","floatShares":5671700,"roa":"1.19%","roe":"-646.34%","lyrEps":-17.3,"volumeRatio":1.198064,"shares":16966900,"dividePrice":0,"high":23.92,"amplitude":0.122008,"preClose":21.31,"low":21.32,"week52Low":11.5,"pbRate":"-1.37","psRate":"0.40","week52High":73.68,"institutionHeld":0,"latestPrice":23.72,"eps":-16.987898,"divideRate":0,"volume":228899,"delay":0,"ttmEps":-16.987898,"open":21.97,"prevYearClose":42.75,"prevWeekClose":23.2,"prevMonthClose":21.17,"prevQuarterClose":21.17,"fiveDayClose":23.2,"twentyDayClose":39.09,"sixtyDayClose":32.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CTEV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-07","symbol":"CTEV","fiscalQuarterEnding":"2026/06","expectedEps":-4.1,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786075200000,"reportTimeType":"pre","actualEps":-3.49},{"market":"US","date":"2026-05-07","symbol":"CTEV","fiscalQuarterEnding":"2026/03","expectedEps":-3.81,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-4.41},{"market":"US","date":"2026-02-23","symbol":"CTEV","fiscalQuarterEnding":"2025/12","expectedEps":-3.96,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1771822800000,"reportTimeType":"post","actualEps":-4.88},{"market":"US","date":"2025-11-07","symbol":"CTEV","fiscalQuarterEnding":"2025/09","expectedEps":-3.12,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"pre","actualEps":-4.07},{"market":"US","date":"2025-08-06","symbol":"CTEV","fiscalQuarterEnding":"2025/06","expectedEps":-2.69,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"pre","actualEps":0.32}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CTEV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CTEV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.6,"hold":0.2,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1780113600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CTEV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CTEV","date":"2026-10-01","current":-1.396288,"percent":0.571788,"low":-3.349365,"twenty":-1.810058,"median":-1.365836,"eighty":-0.554737,"high":-0.170756,"avg":-1.260552,"sd":0.65899,"marketCap":358777791},"quantilePoints":[{"date":"2025-03-07","current":-0.191916,"twenty":-0.197447,"median":-0.191916,"eighty":-0.189456,"marketCap":315861468},{"date":"2025-03-14","current":-0.199101,"twenty":-0.197211,"median":-0.192162,"eighty":-0.187507,"marketCap":327686025},{"date":"2025-03-21","current":-0.195853,"twenty":-0.199101,"median":-0.195853,"eighty":-0.189456,"marketCap":322340677},{"date":"2025-03-28","current":-0.216127,"twenty":-0.207643,"median":-0.197969,"eighty":-0.191424,"marketCap":355708607},{"date":"2025-04-04","current":-0.196739,"twenty":-0.206718,"median":-0.199101,"eighty":-0.19231,"marketCap":323798499},{"date":"2025-04-11","current":-0.193589,"twenty":-0.205793,"median":-0.197132,"eighty":-0.19231,"marketCap":318615132},{"date":"2025-04-17","current":-0.199986,"twenty":-0.20599,"median":-0.198855,"eighty":-0.193117,"marketCap":329143847},{"date":"2025-04-25","current":-0.222131,"twenty":-0.206856,"median":-0.199101,"eighty":-0.193195,"marketCap":365589401},{"date":"2025-05-02","current":-0.218489,"twenty":-0.216127,"median":-0.199986,"eighty":-0.193707,"marketCap":359596132},{"date":"2025-05-09","current":-0.29687,"twenty":-0.216324,"median":-0.201167,"eighty":-0.194022,"marketCap":349553357},{"date":"2025-05-16","current":-0.381783,"twenty":-0.220201,"median":-0.203381,"eighty":-0.19477,"marketCap":449534692},{"date":"2025-05-23","current":-0.40691,"twenty":-0.226382,"median":-0.204415,"eighty":-0.195577,"marketCap":479120156},{"date":"2025-05-30","current":-0.501692,"twenty":-0.309019,"median":-0.20658,"eighty":-0.196207,"marketCap":590723101},{"date":"2025-06-06","current":-0.536032,"twenty":-0.373826,"median":-0.209041,"eighty":-0.196739,"marketCap":631156569},{"date":"2025-06-13","current":-0.526958,"twenty":-0.383151,"median":-0.211797,"eighty":-0.196817,"marketCap":620472929},{"date":"2025-06-20","current":-0.563252,"twenty":-0.405877,"median":-0.216127,"eighty":-0.197014,"marketCap":663207489},{"date":"2025-06-27","current":-0.596754,"twenty":-0.523385,"median":-0.218587,"eighty":-0.197388,"marketCap":702654774},{"date":"2025-07-03","current":-0.634165,"twenty":-0.535753,"median":-0.22026,"eighty":-0.197624,"marketCap":746704243},{"date":"2025-07-11","current":-0.664735,"twenty":-0.548455,"median":-0.222131,"eighty":-0.198609,"marketCap":782699891},{"date":"2025-07-18","current":-0.622299,"twenty":-0.561577,"median":-0.261715,"eighty":-0.199101,"marketCap":732733330},{"date":"2025-07-25","current":-0.582376,"twenty":-0.582376,"median":-0.309814,"eighty":-0.199101,"marketCap":685725314},{"date":"2025-08-01","current":-0.556552,"twenty":-0.579166,"median":-0.371453,"eighty":-0.199593,"marketCap":655318032},{"date":"2025-08-08","current":-1.363933,"twenty":-0.582376,"median":-0.381783,"eighty":-0.199986,"marketCap":904797938},{"date":"2025-08-15","current":-1.684055,"twenty":-0.596754,"median":-0.383039,"eighty":-0.199986,"marketCap":1117158561},{"date":"2025-08-22","current":-1.705165,"twenty":-0.609038,"median":-0.401745,"eighty":-0.201167,"marketCap":1131162171},{"date":"2025-08-29","current":-1.770481,"twenty":-0.629977,"median":-0.507694,"eighty":-0.20166,"marketCap":1174490987},{"date":"2025-09-05","current":-1.68033,"twenty":-0.646839,"median":-0.521375,"eighty":-0.202762,"marketCap":1114687336},{"date":"2025-09-12","current":-1.530824,"twenty":-0.692989,"median":-0.533938,"eighty":-0.203588,"marketCap":1015508829},{"date":"2025-09-19","current":-1.375606,"twenty":-1.377791,"median":-0.536381,"eighty":-0.203963,"marketCap":912541110},{"date":"2025-09-26","current":-1.23802,"twenty":-1.366268,"median":-0.537986,"eighty":-0.204336,"marketCap":821270524},{"date":"2025-10-03","current":-1.152588,"twenty":-1.327376,"median":-0.544198,"eighty":-0.20536,"marketCap":764597092},{"date":"2025-10-10","current":-1.44862,"twenty":-1.376798,"median":-0.552224,"eighty":-0.206383,"marketCap":960977125},{"date":"2025-10-17","current":-1.403918,"twenty":-1.382559,"median":-0.554947,"eighty":-0.207131,"marketCap":931322422},{"date":"2025-10-24","current":-1.649535,"twenty":-1.412162,"median":-0.558366,"eighty":-0.208608,"marketCap":1094258540},{"date":"2025-10-31","current":-1.640594,"twenty":-1.453339,"median":-0.563531,"eighty":-0.2091,"marketCap":1088327600},{"date":"2025-11-07","current":-1.538771,"twenty":-1.530228,"median":-0.579166,"eighty":-0.210084,"marketCap":1020780776},{"date":"2025-11-14","current":-2.137789,"twenty":-1.578507,"median":-0.589565,"eighty":-0.211502,"marketCap":730433464},{"date":"2025-11-21","current":-2.187607,"twenty":-1.633144,"median":-0.596754,"eighty":-0.215261,"marketCap":747454878},{"date":"2025-11-28","current":-2.615165,"twenty":-1.640942,"median":-0.60834,"eighty":-0.216127,"marketCap":893541571},{"date":"2025-12-05","current":-1.787134,"twenty":-1.682416,"median":-0.609806,"eighty":-0.216422,"marketCap":610622545},{"date":"2025-12-12","current":-1.88435,"twenty":-1.687561,"median":-0.622299,"eighty":-0.217741,"marketCap":643839090},{"date":"2025-12-19","current":-1.988338,"twenty":-1.707649,"median":-0.634165,"eighty":-0.218607,"marketCap":679369224},{"date":"2025-12-26","current":-2.064756,"twenty":-1.732682,"median":-0.647217,"eighty":-0.219198,"marketCap":705479742},{"date":"2026-01-02","current":-2.067658,"twenty":-1.769935,"median":-0.66969,"eighty":-0.220083,"marketCap":706471281},{"date":"2026-01-09","current":-1.509511,"twenty":-1.763775,"median":-0.697121,"eighty":-0.220595,"marketCap":515765349},{"date":"2026-01-16","current":-1.45389,"twenty":-1.7451,"median":-1.219145,"eighty":-0.221029,"marketCap":496760858},{"date":"2026-01-23","current":-1.453407,"twenty":-1.733974,"median":-1.267698,"eighty":-0.222131,"marketCap":496595602},{"date":"2026-01-30","current":-1.302504,"twenty":-1.730745,"median":-1.277756,"eighty":-0.226264,"marketCap":445035592},{"date":"2026-02-06","current":-1.243013,"twenty":-1.721556,"median":-1.273802,"eighty":-0.226559,"marketCap":424709050},{"date":"2026-02-13","current":-0.966358,"twenty":-1.711374,"median":-1.266581,"eighty":-0.29687,"marketCap":330182367},{"date":"2026-02-20","current":-1.127418,"twenty":-1.706407,"median":-1.25317,"eighty":-0.305635,"marketCap":385212761},{"date":"2026-02-27","current":-0.825068,"twenty":-1.703973,"median":-1.240517,"eighty":-0.309416,"marketCap":234552084},{"date":"2026-03-06","current":-1.03119,"twenty":-1.699304,"median":-1.200271,"eighty":-0.346407,"marketCap":293148724},{"date":"2026-03-13","current":-0.932787,"twenty":-1.693898,"median":-1.145072,"eighty":-0.367715,"marketCap":265174622},{"date":"2026-03-20","current":-0.893193,"twenty":-1.685808,"median":-1.125483,"eighty":-0.371872,"marketCap":253918770},{"date":"2026-03-27","current":-0.928129,"twenty":-1.68187,"median":-1.089934,"eighty":-0.374385,"marketCap":263850404},{"date":"2026-04-02","current":-0.979951,"twenty":-1.680728,"median":-1.034393,"eighty":-0.379047,"marketCap":278582328},{"date":"2026-04-10","current":-1.041088,"twenty":-1.661853,"median":-1.024785,"eighty":-0.382034,"marketCap":295962687},{"date":"2026-04-17","current":-1.144149,"twenty":-1.646486,"median":-1.027988,"eighty":-0.382369,"marketCap":325261006},{"date":"2026-04-24","current":-1.181996,"twenty":-1.643002,"median":-1.041088,"eighty":-0.383151,"marketCap":336020276},{"date":"2026-05-01","current":-1.416649,"twenty":-1.641469,"median":-1.087406,"eighty":-0.393983,"marketCap":402727750},{"date":"2026-05-08","current":-1.436454,"twenty":-1.640942,"median":-1.117261,"eighty":-0.40141,"marketCap":411577020},{"date":"2026-05-15","current":-1.396438,"twenty":-1.641469,"median":-1.133463,"eighty":-0.404844,"marketCap":400111607},{"date":"2026-05-22","current":-1.401198,"twenty":-1.641023,"median":-1.127418,"eighty":-0.463779,"marketCap":401475430},{"date":"2026-05-29","current":-1.461292,"twenty":-1.640924,"median":-1.144149,"eighty":-0.506494,"marketCap":418693697},{"date":"2026-06-05","current":-1.640383,"twenty":-1.640924,"median":-1.167292,"eighty":-0.515428,"marketCap":470007542},{"date":"2026-06-12","current":-1.905748,"twenty":-1.641657,"median":-1.200271,"eighty":-0.520705,"marketCap":546040681},{"date":"2026-06-18","current":-1.770091,"twenty":-1.674171,"median":-1.236729,"eighty":-0.525172,"marketCap":507171722},{"date":"2026-06-26","current":-2.0658,"twenty":-1.686673,"median":-1.248091,"eighty":-0.528354,"marketCap":591899234},{"date":"2026-07-02","current":-1.927763,"twenty":-1.697502,"median":-1.259914,"eighty":-0.533938,"marketCap":552348363},{"date":"2026-07-10","current":-1.957512,"twenty":-1.711374,"median":-1.268816,"eighty":-0.535753,"marketCap":560872258},{"date":"2026-07-17","current":-1.830185,"twenty":-1.733974,"median":-1.276749,"eighty":-0.536032,"marketCap":524389989},{"date":"2026-07-24","current":-1.384538,"twenty":-1.747881,"median":-1.279495,"eighty":-0.53673,"marketCap":396702050},{"date":"2026-07-31","current":-1.402983,"twenty":-1.736755,"median":-1.28934,"eighty":-0.537065,"marketCap":401986864},{"date":"2026-08-07","current":-1.596949,"twenty":-1.731391,"median":-1.299807,"eighty":-0.537819,"marketCap":457562656},{"date":"2026-08-14","current":-2.527372,"twenty":-1.754145,"median":-1.304922,"eighty":-0.539215,"marketCap":715521887},{"date":"2026-08-21","current":-2.040096,"twenty":-1.770169,"median":-1.307495,"eighty":-0.539856,"marketCap":577569539},{"date":"2026-08-28","current":-2.321447,"twenty":-1.778428,"median":-1.313628,"eighty":-0.546752,"marketCap":657222615},{"date":"2026-09-04","current":-2.340004,"twenty":-1.789196,"median":-1.33854,"eighty":-0.548679,"marketCap":662476328},{"date":"2026-09-11","current":-2.199329,"twenty":-1.792396,"median":-1.346227,"eighty":-0.550828,"marketCap":622649790},{"date":"2026-09-18","current":-1.89942,"twenty":-1.809429,"median":-1.351219,"eighty":-0.552609,"marketCap":537743000},{"date":"2026-09-25","current":-1.398376,"twenty":-1.812438,"median":-1.368494,"eighty":-0.553486,"marketCap":395892735},{"date":"2026-10-01","current":-1.267278,"twenty":-1.810058,"median":-1.365836,"eighty":-0.554737,"marketCap":358777791}],"updateTime":1790997314746},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CTEV\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2636250077","title":"Claritev Corp - Not Informed by DOJ That It Is Target of Investigation - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2636250077","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636250077?lang=en_us&edition=fundamental","pubTime":"2026-05-19 00:02","pubTimestamp":1779120170,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nFWN41V0WC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636077203","title":"Claritev says DOJ antitrust probe has not named company as target","url":"https://stock-news.laohu8.com/highlight/detail?id=2636077203","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636077203?lang=en_us&edition=fundamental","pubTime":"2026-05-19 00:02","pubTimestamp":1779120145,"startTime":"0","endTime":"0","summary":"Claritev issued a Regulation FD clarification addressing a May 14, 2026 article that alleged the DOJ had launched a criminal antitrust probe into the company.The company disclosed it received a confidential DOJ Antitrust Division grand jury subpoena in August 2024 tied to an investigation involving health insurance.Claritev said it has cooperated with the DOJ and has not been told at any point over the past two years that it is a target of the investigation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 18, 2026, an","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nNDL2lGCwb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635730368","title":"Claritev price target raised to $40 from $21 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2635730368","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635730368?lang=en_us&edition=fundamental","pubTime":"2026-05-14 03:19","pubTimestamp":1778699956,"startTime":"0","endTime":"0","summary":"In a sector note on U.S. HealthTech & Distribution, Citi raised the firm’s price target on Claritev (CTEV) to $40 from $21 and keeps a Buy rating o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/claritev-price-target-raised-to-40-from-21-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/claritev-price-target-raised-to-40-from-21-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635786946","title":"Humacyte Announces First Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635786946","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635786946?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:00","pubTimestamp":1778670000,"startTime":"0","endTime":"0","summary":"- Appointed Jim Mercadante as Chief Commercial Officer and Dr. Todd Rasmussen as Chief Surgical Officer - - First quarter sales of Symvess were $0.5 million in 2026 compared to $0.1 million in 2025 - ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/13/3293828/0/en/Humacyte-Announces-First-Quarter-2026-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAA","BK4588","AV","IND","BK4215","BK4585","BK4167","KSA","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634281730","title":"Discovery Health partners smartQare, Cuviva to bolster Care at Home technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2634281730","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634281730?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:56","pubTimestamp":1778504166,"startTime":"0","endTime":"0","summary":"Discovery Limited unit Discovery Health partnered with smartQare, Cuviva, backed by local distributor Airo Health Care, to strengthen technology supporting Discovery Care at Home in South Africa.Collaboration integrates smartQare viQtor medical-grade wearable monitoring with Cuviva Hospital at Home platform to deliver continuous remote monitoring, consolidated patient views, structured care workflows.Discovery Care at Home launched in January 2022, targets hospital-level care for selected acute medical, post-surgical cases, aiming to reduce inpatient admissions or shorten length of stay.Discovery Health estimates about 160,000 of roughly 720,000 annual hospital admissions in its medical scheme could shift to home-based care, implying material capacity, cost benefits if scaled.Discovery Health administers 38.3% of South African medical scheme membership, with Discovery Health Medical Scheme at about 2.7 million members.Disclaimer: This news brief was created by Public Technologies  usin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDLc4Ktmz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634177286","title":"Claritev to present at BofA Securities Global Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2634177286","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634177286?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:02","pubTimestamp":1778500963,"startTime":"0","endTime":"0","summary":"Claritev to meet with investors at BofA Securities 2026 Global Health Care Conference in Las Vegas on May 13, 2026.Management presentation set for 5:00 pm PT on May 13, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via Business Wire  on May 11, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL3CkVLv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","BK4588","LU0417517546.SGD","BK4207","BK4581","LU0477156953.USD","LU0106831901.USD","IE00BBT3K403.USD","LU0320765646.SGD","BK4553","LU1668664300.SGD","LU2129689605.HKD","LU1363072403.SGD","LU0149725797.USD","LU0211331839.USD","LU0256863902.USD","BK4167","LU0310800965.SGD","LU0640476718.USD","IE00BZ1G4Q59.USD","LU2129689431.USD","LU0052756011.USD","LU0980610538.SGD","LU0321505868.SGD","LU0320765489.SGD","LU0971096721.USD","IE00B19Z3B42.SGD","LU0130102774.USD","CTEV","LU0477156797.USD","LU0130518102.USD","LU1496350171.SGD","BK4534","IE00BFXG1179.USD","LU0314106906.USD","LU1791807156.HKD","LU1883839398.USD","BAC","LU1162221912.USD","LU2133065610.SGD","LU0256863811.USD","IE00B1BXHZ80.USD","LU1366192091.USD","LU0208291251.USD","LU0128525689.USD","LU1035773651.USD","LU2265009873.SGD","LU0234570918.USD","LU1201861249.SGD","LU0306806265.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633453260","title":"Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Thermo Fisher (TMO) and Claritev (CTEV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633453260","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633453260?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:40","pubTimestamp":1778240417,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zymeworks (ZYME), Thermo Fisher (TMO) and Claritev (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zymeworks-zyme-thermo-fisher-tmo-and-claritev-ctev-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zymeworks-zyme-thermo-fisher-tmo-and-claritev-ctev-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2360108059.USD","ZYME","IE00B19Z8W00.USD","LU0528227936.USD","LU1923622291.USD","LU2125910336.SGD","LU2764262908.HKD","LU0345770993.USD","BK4167","LABU","BK4533","BK4139","LU2764263203.CNY","BK4581","LU2125909593.SGD","LU0070302665.USD","LU2125909759.SGD","TMO","LU2720916845.USD","IE00B1BXHZ80.USD","IE0034235188.USD","LU0096362180.USD","BK4535","LU2092937221.SGD","LU2125909916.SGD","BK4548","BK4137","XLV","LU1153585028.USD","LU2543165471.USD","LU0029874061.USD","LU0316494557.USD","LU0266013472.USD","BK4121","LU2298321311.HKD","LU2112291526.USD","LU0208291251.USD","LU1291159041.SGD","IE00B4R5TH58.HKD","LU2764263039.SGD","XBI","CTEV","LU0114720955.EUR","LU1057294990.SGD","LU1633808545.USD","LU2211814178.USD","LU2468319806.SGD","HCSG","LU1061106388.HKD","LU1791710400.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633315194","title":"Claritev (CTEV) Gets a Buy from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2633315194","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633315194?lang=en_us&edition=fundamental","pubTime":"2026-05-08 17:41","pubTimestamp":1778233302,"startTime":"0","endTime":"0","summary":"In a report released today, Glen Santangelo from Barclays maintained a Buy rating on Claritev, with a price target of $28.00. According to TipRanks...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/claritev-ctev-gets-a-buy-from-barclays-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/claritev-ctev-gets-a-buy-from-barclays-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633128118","title":"Claritev Corp reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2633128118","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633128118?lang=en_us&edition=fundamental","pubTime":"2026-05-07 21:32","pubTimestamp":1778160736,"startTime":"0","endTime":"0","summary":"Claritev Corp reports results for the quarter ended March 31 - Earnings SummaryClaritev Corp CTEV.N reported a quarterly adjusted loss of $4.41 per share for the quarter ended March 31, lower than the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nL8N41K1PR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633117954","title":"Claritev Q1 revenue beats estimates, lifts 2026 outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2633117954","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633117954?lang=en_us&edition=fundamental","pubTime":"2026-05-07 18:10","pubTimestamp":1778148656,"startTime":"0","endTime":"0","summary":"Claritev Q1 revenue beats estimates, lifts 2026 outlookOverviewUS healthcare data platform's Q1 revenue rose 5.8%, beating analyst expectationsQ1 adjusted EBITDA increased 3.4% and slightly beat analy","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nL1N41K0GE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633112230","title":"Claritev Q1 EPS $(4.41) Misses $(3.85) Estimate, Sales $244.678M Beat $236.389M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2633112230","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633112230?lang=en_us&edition=fundamental","pubTime":"2026-05-07 18:02","pubTimestamp":1778148125,"startTime":"0","endTime":"0","summary":"Claritev (NYSE:CTEV) reported quarterly losses of $(4.41) per share which missed the analyst consensus estimate of $(3.85) by 14.55 percent. This is a 0.68 percent decrease over losses of $(4.38) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52356702/claritev-q1-eps-4-41-misses-3-85-estimate-sales-244-678m-beat-236-389m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633977112","title":"BRIEF-Claritev Corp Q1 Revenue USD 244.678 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633977112","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633977112?lang=en_us&edition=fundamental","pubTime":"2026-05-07 18:00","pubTimestamp":1778148045,"startTime":"0","endTime":"0","summary":"May 07  - Claritev Corp Q1 pretax profit USD -92.721 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLX1E0406:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633411268","title":"Claritev Corp Q1 Net Income USD -73.56 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633411268","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633411268?lang=en_us&edition=fundamental","pubTime":"2026-05-07 18:00","pubTimestamp":1778148001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLX1E0406:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633112394","title":"Claritev Corp Q1 Pretax Profit USD -92.721 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633112394","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633112394?lang=en_us&edition=fundamental","pubTime":"2026-05-07 18:00","pubTimestamp":1778148001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLX1E0406:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633129011","title":"Press Release: Claritev Corporation Reports First Quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633129011","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633129011?lang=en_us&edition=fundamental","pubTime":"2026-05-07 18:00","pubTimestamp":1778148000,"startTime":"0","endTime":"0","summary":"--  Q1 2026 Revenues of $244.7 million grew 5.8% compared to Q1 2025. --  Adjusted EBITDA of $146.9 million increased 3.4% compared to Q1 2025. Claritev Corporation  , a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the first quarter ended March 31, 2026.\"Claritev kicked off 2026 the same way we closed 2025, outperforming on the top and bottom lines with focused execution in sales, operations and financials. We are operating with confidence -- confidence in our team, confidence in our growth, and confidence in the durability of the foundation we are building,\" said Travis Dalton, Chairman, CEO and President of Claritev.--  Adjusted EBITDA of $146.9 million for Q1 2026, an increase of 3.4%,--  Free Cash Flow of $ million for Q1 2026, compared to F","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","VHT","BK4588","BK4561","BK4581","CTEV","BK4585","BK4144","IXJ","ET","BK4550","BK4590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633943028","title":"Claritev Corp  expected to post a loss of $4.01 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2633943028","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633943028?lang=en_us&edition=fundamental","pubTime":"2026-05-05 21:05","pubTimestamp":1777986306,"startTime":"0","endTime":"0","summary":"Claritev Corp  expected to post a loss of $4.01 a share - Earnings Preview Claritev Corp CTEV.N, CTEV.K is expected to  show a rise in quarterly revenue when it reports  results on May 7 for the perio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nL8N41I1PL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632266185","title":"Claritev shareholders approve 2,375,000-share increase to omnibus incentive plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2632266185","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632266185?lang=en_us&edition=fundamental","pubTime":"2026-05-01 04:40","pubTimestamp":1777581625,"startTime":"0","endTime":"0","summary":"Claritev held its annual shareholder meeting on April 29, 2026.Investors adopted an amendment to Claritev 2020 Omnibus Incentive Plan, increasing shares reserved for issuance by 2,375,000.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 30, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDLNRR34:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629336847","title":"Claritev Initiated at Overweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2629336847","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629336847?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:52","pubTimestamp":1777038720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CTEV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 24, 2026 09:52 ET (13:52 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628402057","title":"Claritev schedules first-quarter earnings conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2628402057","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628402057?lang=en_us&edition=fundamental","pubTime":"2026-04-20 20:01","pubTimestamp":1776686482,"startTime":"0","endTime":"0","summary":"Claritev will release first-quarter fiscal 2026 results before market open on May 7, 2026.Earnings conference call set for 8:00 a.m. ET on May 7, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via Business Wire  on April 20, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDLbfrWzb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622823793","title":"Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2622823793","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622823793?lang=en_us&edition=fundamental","pubTime":"2026-03-27 19:00","pubTimestamp":1774609200,"startTime":"0","endTime":"0","summary":"- Total revenues from sales and research collaborations were $0.5 million for fourth quarter and $2.0 million for full year - - Purchase commitment received for a minimum of $1.475 million for a clini","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/27/3263668/0/en/Humacyte-Announces-Fourth-Quarter-and-Year-End-2025-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4142","BK4585","BK4588","CTEV","LU0053671581.USD","IND","BK4167","KSA","VAC","MAA","BK4215"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":5,"totalSize":100,"code":"91000000","status":"200"}]}}